Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ukena

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Lung Cancer (Amsterdam, Netherlands)|March 11, 1998
A phase I study of paclitaxel in combination with etoposide in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)D Ukena, M Berg, M Leutz, et al.
Journal of Medicinal Chemistry|January 1, 1987
Xanthine functionalized congeners as potent ligands at A2-adenosine receptorsK A Jacobson, D Ukena, W Padgett, et al.
Biochemical Pharmacology|May 15, 1989
PAF-receptors on eosinophils: identification with a novel ligand, [3H]WEB 2086D Ukena, C Krogel, G Dent, et al.
Biochemical Pharmacology|May 15, 1987
Molecular probes for extracellular adenosine receptorsK A Jacobson, D Ukena, W Padgett, et al.
Pneumologie (Stuttgart, Germany)|July 20, 1999
[Thoracic actinomycosis--a case report]M Enders, K Reitnauer, M Girmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 1, 1995
[Tumor markers as prognostic factors in non-small-cell bronchial carcinoma]C Nieder, U Nestle, D Ukena, et al.
Journal of Medicinal Chemistry|March 1, 1988
8-Aryl-and 8-cycloalkyl-1,3-dipropylxanthines: further potent and selective antagonists for A1-adenosine receptorsM T Shamim, D Ukena, W L Padgett, et al.
Medizinische Klinik (Munich, Germany : 1983)|May 30, 2009
[Non-small cell lung cancer (NSCLC) stage IIIA/IIIB. A pilot study of neoadjuvant chemotherapy with paclitaxel and carboplatin]D Ukena, M Leutz, P Schlimmer, et al.
Nuklearmedizin. Nuclear Medicine|June 2, 2000
[Silicosis callosities or bronchial carcinoma: on the problem of functional differentiation using FDG-PET]L Zell, D Hellwig, A Sommerfeld, et al.
Pneumologie (Stuttgart, Germany)|March 1, 1997
[Therapy of nocturnal asthma: salmeterol versus nocturnal administration of retard theophylline--comparison of effectiveness and tolerance]D Ukena, I Koper, H Braun, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Lung Cancer (Amsterdam, Netherlands)|March 11, 1998
A phase I study of paclitaxel in combination with etoposide in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)D Ukena, M Berg, M Leutz, et al.
Journal of Medicinal Chemistry|January 1, 1987
Xanthine functionalized congeners as potent ligands at A2-adenosine receptorsK A Jacobson, D Ukena, W Padgett, et al.
Biochemical Pharmacology|May 15, 1989
PAF-receptors on eosinophils: identification with a novel ligand, [3H]WEB 2086D Ukena, C Krogel, G Dent, et al.
Biochemical Pharmacology|May 15, 1987
Molecular probes for extracellular adenosine receptorsK A Jacobson, D Ukena, W Padgett, et al.
Pneumologie (Stuttgart, Germany)|July 20, 1999
[Thoracic actinomycosis--a case report]M Enders, K Reitnauer, M Girmann, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 1, 1995
[Tumor markers as prognostic factors in non-small-cell bronchial carcinoma]C Nieder, U Nestle, D Ukena, et al.
Journal of Medicinal Chemistry|March 1, 1988
8-Aryl-and 8-cycloalkyl-1,3-dipropylxanthines: further potent and selective antagonists for A1-adenosine receptorsM T Shamim, D Ukena, W L Padgett, et al.
Medizinische Klinik (Munich, Germany : 1983)|May 30, 2009
[Non-small cell lung cancer (NSCLC) stage IIIA/IIIB. A pilot study of neoadjuvant chemotherapy with paclitaxel and carboplatin]D Ukena, M Leutz, P Schlimmer, et al.
Nuklearmedizin. Nuclear Medicine|June 2, 2000
[Silicosis callosities or bronchial carcinoma: on the problem of functional differentiation using FDG-PET]L Zell, D Hellwig, A Sommerfeld, et al.
Pneumologie (Stuttgart, Germany)|March 1, 1997
[Therapy of nocturnal asthma: salmeterol versus nocturnal administration of retard theophylline--comparison of effectiveness and tolerance]D Ukena, I Koper, H Braun, et al.
Pageof 12